Upgrade Now

Company Announcements

Holding(s) in Company

Related Companies

By LSE RNS

RNS Number : 9180E
Mediclinic International PLC
11 May 2017
 

Mediclinic International plc

(Incorporated in England and Wales)

Company Number 8338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

 

11 May 2017

 

 

Notification of Major Interest in Mediclinic International plc shares

 

 

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Mediclinic International plc

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to the
notification obligation:

Coronation Asset Management (Pty) Ltd

4. Full name of shareholder(s)
 (if different from 3.):

N/A

5. Date of the transaction and date on
which the threshold is crossed or
reached:

11 May 2017

6. Date on which issuer notified:

11 May 2017

7. Threshold(s) that is/are crossed or
reached:

 

 

5%

8. Notified details:

 

A: Voting rights attached to shares

 

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

 

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

 

Direct

Direct

Indirect

Direct

Indirect

 

GB00B8HX8Z88

37 306 089

37 306 089

36 139 844

36 139 844

 

4.90%

 

 

 

 

 

 

B: Qualifying Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

 

 

 

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

 

 

 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

 

36 139 844

4.90%

 

 

 

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

 

 

 

 

 

Proxy Voting:

 

10. Name of the proxy holder:

Coronation Asset Management (Pty) Ltd

 

11. Number of voting rights proxy holder will cease
to hold:

 

 

12. Date on which proxy holder will cease to hold
voting rights:

 

 

 

 


13. Additional information:

 

 

14. Contact name:

Jamie Rowland

 

15. Contact telephone number:

+27 21 680 2000

 
                                     

 

Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South

Africa and on the NSX in Namibia.

 

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International plc

James Arnold, Head of Investor Relations

ir@mediclinic.com

Capita Company Secretarial Services Limited

Victoria Dalby

+44 (0)207 954 9600


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUAOSRBAAVAAR

Top of Page